Innovation, Accelerated.
Advancing Innovation Through Collaborative Research & Development Engagements
Research Collaborations
Improving clinical outcomes through innovation requires a multi-disciplinary approach to research and development.
Virscio is progressing a diverse portfolio of programs that promise to accelerate more efficient development of novel medicines and improve clinical success. Our R&D activities are supported by a variety of external funding and industry collaborations to align scientific resources to meeting the most pressing translational and therapeutic needs.
These programs span new in vivo model development to enhanced computational science and cross-species data mining to improve modality, model, and target alignment to achieve translational success. Our ability to study a demographically diverse primate population with phenotypes relevant to specific scientific aims provides a unique resource to advance these innovations.
If you have an interest in advancing translational model, tools, data, or technologies that align to our mission of improving clinical outcomes through better preclinical modeling, contact us.
You can reach our scientific team at research@virscio.com.
COLLABORATIONS
Frequently Asked Questions
What are biological advantages of utilizing African green monkeys from the St. Kitts colony?
What are biological advantages of utilizing African green monkeys from the St. Kitts colony?
How many monkeys are there in St. Kitts?
How many monkeys are there in St. Kitts?
Can I use US grant funding to support studies at your research site in St. Kitts?
Can I use US grant funding to support studies at your research site in St. Kitts?
Yes. As a US company, Virscio has a long history of successfully securing NIH and other US government grant funding to support research and development programs. Additionally, we are frequently supporting academic and industry-sponsored programs that have been funded by the RO1, SBIR, ARPA-H, and other granting mechanisms and agencies.